Cargando…
Whole-exome sequencing identifies prognostic mutational signatures in gastric cancer
BACKGROUND: Gastric cancer (GC) is a heterogeneous disease, and is a leading cause of cancer deaths in Eastern Asia. Genomic analysis, such as whole-exome sequencing (WES), can help identify key genetic alterations leading to the malignancy and diversity of GC, and may help identify new drug targets...
Autores principales: | Zhu, Zhenxin, Fu, Hongbing, Wang, Shengzhou, Yu, Xinxin, You, Qing, Shi, Mengyao, Dai, Chun, Wang, Guan, Cha, Wei, Wang, Weimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729362/ https://www.ncbi.nlm.nih.gov/pubmed/33313229 http://dx.doi.org/10.21037/atm-20-6620 |
Ejemplares similares
-
Whole exome sequencing identifies mutational signatures of vitreoretinal lymphoma
por: Lee, Junwon, et al.
Publicado: (2020) -
Whole-Exome Sequencing Reveals Mutational Signature of Hypertrophic Cardiomyopathy
por: Wang, Xi-Qin, et al.
Publicado: (2023) -
Failure to Identify Somatic Mutations in Monozygotic Twins Discordant for Schizophrenia by Whole Exome Sequencing
por: Lyu, Nan, et al.
Publicado: (2016) -
Whole-exome sequencing to identify somatic mutations in peritoneal metastatic gastric adenocarcinoma: A preliminary study
por: Liu, Hao, et al.
Publicado: (2016) -
Whole Genome Messenger RNA Profiling Identifies a Novel Signature to Predict Gastric Cancer Survival
por: Dai, Jin, et al.
Publicado: (2019)